Bank of New York Mellon Corp - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 33 filers reported holding CONATUS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$43,000
-21.8%
137,5000.0%0.00%
Q4 2019$55,000
+27.9%
137,5000.0%0.00%
Q3 2019$43,000
+19.4%
137,5000.0%0.00%
Q2 2019$36,000
-79.2%
137,500
-13.7%
0.00%
Q1 2019$173,000
-37.5%
159,390
-0.4%
0.00%
Q4 2018$277,000
-70.4%
160,069
-0.9%
0.00%
Q3 2018$937,000
+31.8%
161,449
-2.6%
0.00%
Q2 2018$711,000
-44.7%
165,834
-24.3%
0.00%
Q1 2018$1,286,000
+29.0%
219,009
+1.5%
0.00%
Q4 2017$997,000
-1.3%
215,843
+17.3%
0.00%
Q3 2017$1,010,000
+34.5%
184,021
+41.2%
0.00%
Q2 2017$751,000
+61.9%
130,343
+62.3%
0.00%
Q1 2017$464,000
+12.1%
80,310
+2.1%
0.00%
Q4 2016$414,000
+158.8%
78,655
-1.9%
0.00%
Q3 2016$160,000
-10.1%
80,200
-7.1%
0.00%
Q2 2016$178,000
-1.7%
86,296
+2.0%
0.00%
Q1 2016$181,000
-25.8%
84,6280.0%0.00%
Q4 2015$244,000
-13.8%
84,628
+33.1%
0.00%
Q3 2015$283,000
-46.8%
63,604
-38.5%
0.00%
Q2 2015$532,000
-33.3%
103,358
-7.8%
0.00%
Q1 2015$798,000
+87.8%
112,090
+84.4%
0.00%
Q4 2014$425,000
+20.1%
60,774
+5.1%
0.00%
Q3 2014$354,000
-66.5%
57,815
-50.2%
0.00%
Q2 2014$1,058,000
+81.5%
116,160
+62.1%
0.00%
Q1 2014$583,000
+594.0%
71,676
+452.3%
0.00%
Q4 2013$84,000
-63.5%
12,978
-43.3%
0.00%
Q3 2013$230,00022,8700.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Kalos Management, Inc. 47,500$12,0000.01%
Virtu Financial LLC 94,842$25,0000.00%
ACADIAN ASSET MANAGEMENT LLC 467,425$121,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$6,0000.00%
A.R.T. Advisors, LLC 60,430$16,0000.00%
GOLDMAN SACHS GROUP INC 25,350$7,0000.00%
MORGAN STANLEY 1,019$00.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$6,0000.00%
WOLVERINE TRADING, LLC 30,900$8,0000.00%
WOLVERINE TRADING, LLC 26,779$7,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders